Celltrion, Foreign Investors Net Buy 22,000 Shares... Stock Price Up 1.09%
As of 12:30 PM on the 11th, Celltrion is trading at 371,000 KRW, up 1.09% from the previous day. This marks an 11.24% increase compared to December 28. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have a net purchase of 22,000 shares of Celltrion, while institutions have a net sale of 29,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 347,440 shares, whereas foreigners and institutions have net sold 111,647 shares and 253,078 shares, respectively.
On January 5, Celltrion was a market topic for its "strength following the disclosure of Phase 2 clinical trial results of the COVID-19 antibody treatment."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
